Special Topics in Computational Biology: Rational Design of Proteins and
Drugs 15-873
Instructor
|
Chris Langmead, WeH 4103, cjl at cs.cmu.edu
|
Description
We will read a series of papers on algorithms for drug design and protein
(re)design. We will discuss these algorithms from a variety of perspectives:
their complexity, their fidelity to the underlying physics, and their overall
accuracy when applied. Students will
be required to read present papers and prepare short written summaries of each
paper they present.
Prerequisites:
15-879 or permission of instructor
Course Information
|
Classes: T, TH 6:30
- 7:50 PM ; WeH 4615A
|
|
|
Office Hours: by appointment
|
|
Note: This class does not begin until September 13, due
to the SCS immigration process
Syllabus
|
Date
|
Topic
|
Reading
|
Speaker
|
|
Pre-class reading
|
|
|
|
|
13-Sep
|
Introduction to course, overview of protein and drug
design.
|
(1) Protein Design
Concepts, Steip;
(2) [handout]
Drug design and discovery: an overview, Mitscher
(3) Protein Docking,
Kaapro and Ojanen;
(4) [handout] Computer-aided development and use of
three-dimensional pharmacophore models, Liljefors and Pettersson
|
Chris Langmead
|
|
15-Sep
|
Hardness Results
|
(1) Protein design is
NP-Hard, Pierce and Winfree;
(2) The
Inapproximability of Side-Chain Positioning, Chazelle et al;
|
Group discussion
|
|
20-Sep
|
Force Fields and Energy
Calculations
|
(1)
Factors Affecting the Ability of Energy
Functions to
Discriminate Correct from
Incorrect Folds, Park et al;
(2)
On the design and analysis of protein folding
potentials, Tobi et al
|
Group discussion
|
|
22-Sep
|
Force Fields and Energy
Calculations;
Drug Design:
Rigid Docking 1
|
(1) BIOMOLECULAR
SIMULATIONS: Recent Developments in Force Fields, Simulations of Enzyme
Catalysis, Protein-Ligand, Protein-Protein, and Protein-Nucleic Acid
Noncovalent Interactions, Wang
(2) Modelling Protein
Docking using Shape Complementarity, Electrostatics and Biochemical
Information, Gabb et al;
|
Group discussion
|
|
27-Sep
|
Drug Design:
Rigid Docking 2
|
(1) Efficient Unbound
Docking of Rigid Molecules, Duhovny et al;
(2) Critical Evaluation of
Search Algorithms for Automated Molecular Docking and Database Screening,
Ewing and Kuntz;
|
Group discussion
|
|
29-Sep
|
Drug Design:
Rigid Docking 3
|
(1)
Docking Unbound Proteins with MIAX: A Novel
Algorithm for Protein-Protein Soft Docking, Munoz et al;
(2) Rigid Body Docking for
Virtual Screening, May et al;
|
Group discussion
|
|
4-Oct
|
Drug Design:
Flexible Docking 1
|
(1) Development and
Validation of a Genetic Algorithm for Flexible Docking, Jones et
al;
(2) Improved protein-ligand docking using GOLD, Verdonk et al
|
Hetu Kamisetty
|
|
6-Oct
|
Drug Design:
Flexible Docking 2
|
(1) A Fast Flexible Docking Method using an Incremental
Construction Algorithm, Rarey et al;
(2)
A
method for Biomolecular Structural Recognition and Docking Allowing
Conformational Flexibility, Sandak et al;
|
Group discussion
|
|
11-Oct
|
Drug Design:
Ensemble Docking
|
(1) FLEXE: Efficient Molecular Docking Considering
Protein Structure Variations, Clauben et al;
(2) Study
of a Highly Accurate and Fast Protein-Ligand Docking Algorithm Based on
Molecular Dynamics, Taufer et al;
|
Bob Montgomery
|
|
13-Oct
|
Drug Design:
Ensemble Docking, Scoring Functions 1
|
(1)
Molecular Docking to Ensembles of Protein
Structures, Knegtel et al;
(2) SCORE: A New Empirical
Method for Estimating the Binding Affinity of a Protein-Ligand Complex,
Wang et al;
|
Jacob Joseph
|
|
18-Oct
|
Drug Design: Scoring Functions 2
|
(1) Knowledge-based
Scoring Function to Predicting Protein-Ligand Interactions, Gohlke et
al;
(2) Protein-based virtual screening of chemical
databases. 1. Evaluation of different docking/scoring combinations, Bissantz
et al;
|
Madhavi
Ganapathiraju
|
|
20-Oct
|
Drug Design: Pharmacophores
|
(1)
RAPID: Randomized Pharmacophore Identi
cation for Drug Design, Finn et al;
(2)
Approximation algorithms for 3-D common
substructure identification in drug and protein molecules,
Chakraborty and Biswas
|
Sumit Jha
|
|
25-Oct
|
Drug Design: Machine Learning
|
(1)
Active Learning in the Drug Discovery Process,
Warmuth et al;
______ ___ _____ ___ _ _________
_______________ ___!_!#"__%$
&'_ __$_"__(_
_________ _*)+"__(,-______.
_/___ __$0____/12___ $__
34__/15___%_
(2)
Drug Design by Machine Learning: Support
Vector Machines for Pharmaceutical Data Analysis, Burbidge et
al;
|
Amina Abdulla
|
|
27-Oct
|
Drug Design: Machine Learning
|
|
Amina Abdulla
|
|
1-Nov
|
Protein Design/Side
Chain Placement: Dead End Elimination 1
|
(1) [handout] The dead-end elimination theorem and
its use in protein Side-chain positioning, Desmet et al;
(2)
Theoretical and Algorithmical Optimization of
the Dead-End Elimination Theorem, Desmet and Lasters;
|
Naveena Yanamala
|
|
3-Nov
|
Protein Design/Side
Chain Placement: Dead End Elimination 2
|
(1) Conformational
Splitting: A more powerful criterion for dead-end elimination,
Pierce et al
(2) Generalized
Dead-end Elimination Algorithms Make Large-scale Protein Side-chain
Structure Prediction Tractable: Implications for Protein Design and
Structural Genomics, Looger and Hellinga;
|
Jacob Joseph
|
|
8-Nov
|
Protein Design/Side
Chain Placement: Mean Field Theory and Graph-Theoretic
approaches
|
(1) Application
of a Self-Consistent Mean Field Theory to Predict Protein Side-Chains Conformations
and Estimate Their Conformational Entropy, Koehl and Delarue;
(2) A
graph-theory algorithm for rapid protein side-chain prediction, Canutescu
et al;
|
Sumit Jha
|
|
10-Nov
|
Protein Design/Side
Chain Placement: Branch and Bound and A*
|
(1) A
Multi-Queue Branch-and-Bound Algorithm for Anytime Optimal Search with
Biological Applications, Lathrop et al;
(2) Exploring the conformational space
of protein side chains using dead-end elimination and the A* algorithm,
Leach and Lemon
|
Bob Montgomery
|
|
15-Nov
|
Protein Design/Side Chain
Placement: Genetic Algorithms
|
(1) De novo protein design using pairwise potentials
and a genetic algorithm, Jones
(2)
GEM: A
Gaussian evolutionary method for predicting protein side-chain
conformations, Yang et al
|
Naveena Yanamala
|
|
17-Nov
|
Protein Design: Monte
Carlo 1
|
(1) The Evolutionary Capacity of Protein Structures,
Meyerguz et al
(2) Efficient Algorithms
for Protein Sequence Design and the Analysis of Certain Evolutionary
Fitness Landscapes, Kleinberg
|
Hetu Kamisetty
|
|
22-Nov
|
Protein Design:
Monte Carlo 2; comparison of methods
|
(1) Recapitulation of Protein
Family Divergence using
Flexible
Backbone Protein Design, Saunders and Baker
(2) Trading Accuracy for
Speed: A Quantitative Comparison of Search Algorithms in Protein Sequence
Design, Voigt et al;
|
Bob Montgomery
|
|
24-Nov
|
NO CLASS
|
|
|
|
29-Nov
|
Drug Design: Machine Learning
|
(1)
Kernel Functions for Attributed Molecular
Graphs – A New Similarity Based Approach To ADME Prediction in Classification
and Regression, Frohlick et al;
|
Amina Abdulla
|
|
1-Dec
|
Protein Design:
|
(1) Automatic procedures for protein design, Jaramillo et al;
(2)
Probing sequence-structure
relationships in proteins: Application of simple energy functions to the
inverse folding problem, Elber et al;
|
Madhavi
Ganapathiraju
|
|
6-Dec
|
Protein Design:
Design for function and protein complexes
|
(1) Rational design of
faster associating and tighter binding protein complexes, Selzer et
al
(2) A Novel
EnsembleBased Scoring and Search Algorithm for Protein Redesign, and its
Application to Modify the Substrate Specificity of the Gramicidin
Synthetase A Phenylalanine Adenylation Enzyme; Lilien et al;
|
Aly Azeem Khan
|
|
8-Dec
|
Protein Design:
protein-DNA interactions, nucleic acid design
|
(1) A Simple Physical Model for the Prediction and
Design
of
Protein–DNA Interactions; Havranek et al
(2) Paradigms for computational nucleic acid design,
Dirks et al
|
Aly Azeem Khan
|
Useful Links
IUPAC Glossary of Terms Used
in Computational Drug Design
An Introduction
to QSAR methodology
Drug
Discovery Tutorial
Some Papers we won’t get to, but might be useful as
background
Molecular
Modeling, Broughton;
Computer
simulations of ligand-protein binding with ensembles of protein
conformations: A Monte Carlo study of HIV-1 protease binding energy landscapes, Bouzida
et al
De Novo
Protein Design I: In Search of Stability and Specificity, Koehl and
Levitt
De Novo
Protein Design II: In Plasticity In Sequence Space, Koehl and Levitt
Protein design: a
perspective from simple tractable models, Shakhnovich;
|